1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

1-30 of about 600 reports

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021

  • $ 2000
  • September 2021
  • 44 pages

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney ...

  • World
  • Renal Disease
  • Industry analysis
  • Drug Approval

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021

  • $ 2500
  • September 2021
  • 1013 pages

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Drugs In Development, 2021, ...

  • World
  • Musculoskeletal Disorder
  • Industry analysis

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021

  • $ 3500
  • September 2021
  • 73 pages

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to ...

  • World
  • Therapy
  • Type 2 Diabetes
  • Industry analysis
  • Medicine Use

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021

  • $ 3500
  • September 2021
  • 126 pages

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) ...

  • World
  • United States
  • Biotechnology
  • Monoclonal Antibody
  • Industry analysis
  • Mortality Rate
  • Drug Approval

Retinoic Acid Receptor Gamma - Drugs In Development, 2021

  • $ 3500
  • August 2021
  • 88 pages

Retinoic Acid Receptor Gamma - Drugs In Development, 2021 Summary Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor gamma ...

  • World
  • South Africa
  • Pharmaceutical
  • Therapy
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

  • $ 2500
  • August 2021
  • 401 pages

Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Drugs In Development, 2021, provides an overview of ...

  • World
  • Jiangsu
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Drug Approval
  • In Patient Number

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 137 pages

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Drugs In Development, ...

  • World
  • Shandong
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Number Of R&D Personnel

Bronchiectasis (Respiratory) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 123 pages

Bronchiectasis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provides an overview of ...

  • World
  • Respiratory Disease
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021

  • $ 2500
  • August 2021
  • 675 pages

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease - ...

  • World
  • Respiratory Disease
  • Industry analysis

Asthma (Respiratory) - Drugs In Development, 2021

  • $ 2500
  • August 2021
  • 931 pages

Asthma (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview of the Asthma (Respiratory) ...

  • World
  • Asthma
  • Therapy
  • Industry analysis

Atherosclerosis (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 276 pages

Atherosclerosis (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Drugs In Development, 2021, provides an overview ...

  • World
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Hypertrophic Cardiomyopathy (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 116 pages

Hypertrophic Cardiomyopathy (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Drugs In Development, 2021, ...

  • World
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Interest Payments Paid By Central Government

Stroke (Cardiovascular) - Drugs In Development, 2021

  • $ 2500
  • August 2021
  • 862 pages

Stroke (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Drugs In Development, 2021, provides an overview of the Stroke ( ...

  • World
  • Stroke
  • Cardiology
  • Industry analysis

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 278 pages

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial ...

  • World
  • United States
  • Cardiovascular Disease
  • Industry analysis
  • Mortality Rate
  • Drug Approval

Diabetic Gastroparesis (Gastrointestinal) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 49 pages

Diabetic Gastroparesis (Gastrointestinal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Drugs In Development, 2021, provides ...

  • World
  • Diabetes
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Health Provider Density

Cat Allergy (Immunology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 35 pages

Cat Allergy (Immunology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Drugs In Development, 2021, provides an overview of the Cat ...

  • World
  • Zhejiang
  • Allergy
  • Drug Development
  • Industry analysis
  • Book Sales

Grass Pollen Allergy (Immunology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 85 pages

Grass Pollen Allergy (Immunology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Drugs In Development, 2021, provides an overview ...

  • World
  • Zhejiang
  • Allergy
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Medicine Use

Diabetic Nephropathy (Metabolic Disorder) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 340 pages

Diabetic Nephropathy (Metabolic Disorder) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Drugs In Development, 2021, provides ...

  • Guangdong
  • Type 2 Diabetes
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Medicine Use

Dyslipidemia (Metabolic Disorder) - Drugs In Development, 2021

  • $ 2500
  • July 2021
  • 411 pages

Dyslipidemia (Metabolic Disorder) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Drugs In Development, 2021, provides an overview ...

  • Jiangsu
  • Cholesterol
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Osteoarthritis (Musculoskeletal) - Drugs In Development, 2021

  • $ 2500
  • July 2021
  • 480 pages

Osteoarthritis (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Drugs In Development, 2021, provides an overview ...

  • World
  • Taiwan
  • Arthritis
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Myocardial Infarction (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 439 pages

Myocardial Infarction (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Drugs In Development, 2021, provides ...

  • World
  • Japan
  • Heart Attack
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Deep Vein Thrombosis (DVT) (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 36 pages

Deep Vein Thrombosis (DVT) (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Deep Vein Thrombosis - Drugs In Development, 2021, provides ...

  • World
  • South Korea
  • Blood Disease
  • Cardiovascular Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 426 pages

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Drugs In Development, ...

  • South Africa
  • Drug Development
  • Hypertension
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Malignant Pleural Effusion (Respiratory) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 54 pages

Malignant Pleural Effusion (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Effusion - Drugs In Development, 2021, ...

  • World
  • Jiangsu
  • Respiratory Disease
  • Drug Development
  • Industry analysis
  • Life Insurance Claims

Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 68 pages

Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorder) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Proliferative Diabetic Retinopathy - ...

  • World
  • Type 2 Diabetes
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Manufacturing Output

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 218 pages

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Drugs In Development, 2021, provides an overview ...

  • World
  • China
  • Respiratory Disease
  • Allergy Drug
  • Industry analysis
  • Pharmaceutical Registrations
  • Medicine Use

Angina (Angina Pectoris) (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 104 pages

Angina (Angina Pectoris) (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Angina - Drugs In Development, 2021, provides an overview ...

  • World
  • Jiangsu
  • Angina
  • Industry analysis
  • Pharmaceutical Registrations
  • Surgical Procedures Performed

Low Back Pain (Central Nervous System) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 164 pages

Low Back Pain (Central Nervous System) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Drugs In Development, 2021, provides an overview ...

  • World
  • Chronic Pain
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Osteoarthritis Pain (Central Nervous System) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 291 pages

Osteoarthritis Pain (Central Nervous System) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain - Drugs In Development, 2021, provides ...

  • Taiwan
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Surgical Procedures Performed

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 172 pages

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Drugs In Development, ...

  • World
  • Renal Disease
  • Drug Development
  • Industry analysis
  • Drug Approval
  • In Patient Average Length Of Stay
About 24000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Diabetes Industry in the US

  • October 2021
  • 19 pages
  • United States
  • North America
  • Diabetes
  • Cardiovascular Disease
  • Industry analysis
  • Diabetes Prevalence
  • Hospital Occupancy Rate

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on